Boston Partners
TARO

Boston Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Boston Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,643
Closed -$1.24M – 738
2018
Q4 		$1.24M Sell
14,643
-8,258
-36% -$796K ﹤0.01% 620
2018
Q3 		$2.25M Sell
22,901
-640
-3% -$69.3K ﹤0.01% 590
2018
Q2 		$2.72M Buy
+23,541
New +$2.59M ﹤0.01% 604
2016
Q3 		– Sell
-11,503
Closed -$1.68M – 770
2016
Q2 		$1.68M Buy
11,503
+931
+9% +$132K ﹤0.01% 662
2016
Q1 		$1.51M Hold
10,572
– – ﹤0.01% 649
2015
Q4 		$1.63M Buy
+10,572
New +$1.54M ﹤0.01% 637

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Boston Partners's TARO Position: Q1 2019 in Review

Boston Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2019, closing a stake of 14,643 shares — an estimated $1.24M sold.

Boston Partners first reported a position in TARO in Q4 2015 and held it in 6 quarters. The position peaked at $2.72M in Q2 2018. 104 funds tracked by Wall St. Rank hold TARO as of Q1 2019.

  • Boston Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2019 after selling out during the quarter.
  • Boston Partners sold 14,643 Taro Pharmaceutical Industries Ltd. shares in Q1 2019, an estimated $1.24M.
  • Boston Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 6 quarters.
  • Boston Partners's Taro Pharmaceutical Industries Ltd. position peaked at $2.72M in Q2 2018.
  • 104 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2019.

Based on Boston Partners's 13F filing for Q1 2019, filed 3 May 2019.